Annual Gross Profit
$3.40 B
+$279.77 M+8.97%
31 December 2023
Summary:
Jazz Pharmaceuticals annual gross profit is currently $3.40 billion, with the most recent change of +$279.77 million (+8.97%) on 31 December 2023. During the last 3 years, it has risen by +$1.18 billion (+53.46%). JAZZ annual gross profit is now at all-time high.JAZZ Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$943.36 M
+$29.43 M+3.22%
30 September 2024
Summary:
Jazz Pharmaceuticals quarterly gross profit is currently $943.36 million, with the most recent change of +$29.43 million (+3.22%) on 30 September 2024. Over the past year, it has increased by +$73.37 million (+8.43%). JAZZ quarterly gross profit is now at all-time high.JAZZ Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$3.57 B
+$73.37 M+2.10%
30 September 2024
Summary:
Jazz Pharmaceuticals TTM gross profit is currently $3.57 billion, with the most recent change of +$73.37 million (+2.10%) on 30 September 2024. Over the past year, it has increased by +$269.77 million (+8.18%). JAZZ TTM gross profit is now at all-time high.JAZZ TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.0% | +8.4% | +8.2% |
| 3 y3 years | +53.5% | +36.1% | +42.3% |
| 5 y5 years | +92.1% | +86.3% | +84.2% |
JAZZ Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +53.5% | at high | +36.1% | at high | +42.3% |
| 5 y | 5 years | at high | +92.1% | at high | +86.4% | at high | +84.2% |
| alltime | all time | at high | >+9999.0% | at high | +7706.0% | at high | >+9999.0% |
Jazz Pharmaceuticals Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $943.36 M(+3.2%) | $3.57 B(+2.1%) |
| June 2024 | - | $913.92 M(+13.3%) | $3.50 B(+1.6%) |
| Mar 2024 | - | $806.50 M(-10.9%) | $3.44 B(+1.2%) |
| Dec 2023 | $3.40 B(+9.0%) | $904.69 M(+4.0%) | $3.40 B(+3.0%) |
| Sept 2023 | - | $869.99 M(+1.2%) | $3.30 B(+1.9%) |
| June 2023 | - | $859.78 M(+12.5%) | $3.24 B(+1.6%) |
| Mar 2023 | - | $764.17 M(-5.0%) | $3.18 B(+2.1%) |
| Dec 2022 | $3.12 B(+17.5%) | $804.76 M(-0.3%) | $3.12 B(+1.4%) |
| Sept 2022 | - | $806.99 M(-0.2%) | $3.07 B(+3.9%) |
| June 2022 | - | $808.67 M(+15.8%) | $2.96 B(+6.3%) |
| Mar 2022 | - | $698.44 M(-8.2%) | $2.78 B(+4.9%) |
| Dec 2021 | $2.65 B(+19.8%) | $760.58 M(+9.8%) | $2.65 B(+5.8%) |
| Sept 2021 | - | $692.89 M(+9.5%) | $2.51 B(+5.6%) |
| June 2021 | - | $632.62 M(+11.5%) | $2.37 B(+4.3%) |
| Mar 2021 | - | $567.39 M(-7.8%) | $2.28 B(+2.8%) |
| Dec 2020 | $2.21 B(+8.9%) | $615.36 M(+10.1%) | $2.21 B(+3.2%) |
| Sept 2020 | - | $558.79 M(+4.6%) | $2.15 B(+2.5%) |
| June 2020 | - | $534.43 M(+5.6%) | $2.09 B(+1.4%) |
| Mar 2020 | - | $506.07 M(-7.4%) | $2.07 B(+1.5%) |
| Dec 2019 | $2.03 B(+14.9%) | $546.39 M(+7.9%) | $2.03 B(+5.0%) |
| Sept 2019 | - | $506.30 M(-0.0%) | $1.94 B(+3.4%) |
| June 2019 | - | $506.46 M(+6.7%) | $1.87 B(+2.2%) |
| Mar 2019 | - | $474.68 M(+5.5%) | $1.83 B(+3.6%) |
| Dec 2018 | $1.77 B(+17.3%) | $450.12 M(+1.7%) | $1.77 B(+2.3%) |
| Sept 2018 | - | $442.80 M(-4.9%) | $1.73 B(+3.7%) |
| June 2018 | - | $465.76 M(+13.4%) | $1.67 B(+6.4%) |
| Mar 2018 | - | $410.69 M(-0.1%) | $1.57 B(+4.0%) |
| Dec 2017 | $1.51 B(+9.1%) | $411.15 M(+8.0%) | $1.51 B(+3.3%) |
| Sept 2017 | - | $380.65 M(+4.1%) | $1.46 B(+2.2%) |
| June 2017 | - | $365.71 M(+4.2%) | $1.43 B(+0.6%) |
| Mar 2017 | - | $350.99 M(-3.3%) | $1.42 B(+2.8%) |
| Dec 2016 | $1.38 B(+13.1%) | $362.96 M(+3.7%) | $1.38 B(+3.5%) |
| Sept 2016 | - | $349.87 M(-2.0%) | $1.34 B(+2.9%) |
| June 2016 | - | $357.18 M(+14.3%) | $1.30 B(+3.6%) |
| Mar 2016 | - | $312.57 M(-1.4%) | $1.25 B(+2.6%) |
| Dec 2015 | $1.22 B | $316.85 M(+1.4%) | $1.22 B(+1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2015 | - | $312.49 M(+0.2%) | $1.20 B(+2.8%) |
| June 2015 | - | $311.93 M(+11.0%) | $1.17 B(+4.6%) |
| Mar 2015 | - | $281.00 M(-6.1%) | $1.12 B(+6.2%) |
| Dec 2014 | $1.06 B(+37.0%) | $299.33 M(+7.1%) | $1.06 B(+9.2%) |
| Sept 2014 | - | $279.59 M(+7.3%) | $966.25 M(+8.0%) |
| June 2014 | - | $260.54 M(+20.6%) | $894.57 M(+9.5%) |
| Mar 2014 | - | $216.00 M(+2.8%) | $817.25 M(+6.1%) |
| Dec 2013 | $770.28 M(+51.8%) | $210.13 M(+1.1%) | $770.28 M(+7.3%) |
| Sept 2013 | - | $207.91 M(+13.5%) | $718.09 M(+10.0%) |
| June 2013 | - | $183.22 M(+8.4%) | $653.06 M(+12.3%) |
| Mar 2013 | - | $169.02 M(+7.0%) | $581.78 M(+14.6%) |
| Dec 2012 | $507.55 M(+96.5%) | $157.94 M(+10.5%) | $507.55 M(+18.2%) |
| Sept 2012 | - | $142.89 M(+27.6%) | $429.29 M(+20.7%) |
| June 2012 | - | $111.94 M(+18.1%) | $355.79 M(+16.6%) |
| Mar 2012 | - | $94.79 M(+19.0%) | $305.05 M(+18.1%) |
| Dec 2011 | $258.33 M(+61.2%) | $79.67 M(+14.8%) | $258.33 M(+13.7%) |
| Sept 2011 | - | $69.39 M(+13.4%) | $227.25 M(+13.9%) |
| June 2011 | - | $61.20 M(+27.3%) | $199.52 M(+13.4%) |
| Mar 2011 | - | $48.07 M(-1.1%) | $176.00 M(+9.8%) |
| Dec 2010 | $160.22 M(+34.9%) | $48.59 M(+16.6%) | $160.22 M(+8.9%) |
| Sept 2010 | - | $41.66 M(+10.6%) | $147.14 M(+9.8%) |
| June 2010 | - | $37.68 M(+16.7%) | $133.95 M(+2.3%) |
| Mar 2010 | - | $32.29 M(-9.0%) | $130.97 M(+10.2%) |
| Dec 2009 | $118.81 M(+121.7%) | $35.50 M(+24.7%) | $118.81 M(+19.3%) |
| Sept 2009 | - | $28.47 M(-18.0%) | $99.60 M(+19.5%) |
| June 2009 | - | $34.70 M(+72.4%) | $83.35 M(+35.8%) |
| Mar 2009 | - | $20.13 M(+23.6%) | $61.39 M(+14.5%) |
| Dec 2008 | $53.59 M(-5.0%) | $16.29 M(+33.3%) | $53.59 M(+8.3%) |
| Sept 2008 | - | $12.22 M(-4.1%) | $49.49 M(-12.9%) |
| June 2008 | - | $12.74 M(+3.3%) | $56.81 M(+0.3%) |
| Mar 2008 | - | $12.34 M(+1.2%) | $56.65 M(+0.4%) |
| Dec 2007 | $56.40 M(+48.9%) | $12.19 M(-37.6%) | $56.40 M(+27.6%) |
| Sept 2007 | - | $19.54 M(+55.2%) | $44.21 M(+79.2%) |
| June 2007 | - | $12.59 M(+4.1%) | $24.67 M(+104.1%) |
| Mar 2007 | - | $12.09 M | $12.09 M |
| Dec 2006 | $37.89 M(+120.9%) | - | - |
| Dec 2005 | $17.15 M | - | - |
FAQ
- What is Jazz Pharmaceuticals annual gross profit?
- What is the all time high annual gross profit for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual gross profit year-on-year change?
- What is Jazz Pharmaceuticals quarterly gross profit?
- What is the all time high quarterly gross profit for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly gross profit year-on-year change?
- What is Jazz Pharmaceuticals TTM gross profit?
- What is the all time high TTM gross profit for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals TTM gross profit year-on-year change?
What is Jazz Pharmaceuticals annual gross profit?
The current annual gross profit of JAZZ is $3.40 B
What is the all time high annual gross profit for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual gross profit is $3.40 B
What is Jazz Pharmaceuticals annual gross profit year-on-year change?
Over the past year, JAZZ annual gross profit has changed by +$279.77 M (+8.97%)
What is Jazz Pharmaceuticals quarterly gross profit?
The current quarterly gross profit of JAZZ is $943.36 M
What is the all time high quarterly gross profit for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly gross profit is $943.36 M
What is Jazz Pharmaceuticals quarterly gross profit year-on-year change?
Over the past year, JAZZ quarterly gross profit has changed by +$73.37 M (+8.43%)
What is Jazz Pharmaceuticals TTM gross profit?
The current TTM gross profit of JAZZ is $3.57 B
What is the all time high TTM gross profit for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high TTM gross profit is $3.57 B
What is Jazz Pharmaceuticals TTM gross profit year-on-year change?
Over the past year, JAZZ TTM gross profit has changed by +$269.77 M (+8.18%)